Catharina Larsson
#158,465
Most Influential Person Now
Swedish geneticist
Catharina Larsson's AcademicInfluence.com Rankings
Catharina Larssonbiology Degrees
Biology
#12363
World Rank
#15834
Historical Rank
Genetics
#1359
World Rank
#1461
Historical Rank
Molecular Biology
#1994
World Rank
#2026
Historical Rank
Download Badge
Biology
Catharina Larsson's Degrees
- Bachelors Biology Uppsala University
- PhD Genetics Lund University
Similar Degrees You Can Earn
Why Is Catharina Larsson Influential?
(Suggest an Edit or Addition)Catharina Larsson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma (1988) (990)
- Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria (2001) (835)
- HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome (2002) (658)
- Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. (2003) (520)
- BRCA2 mutations in primary breast and ovarian cancers (1996) (390)
- Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays (2000) (307)
- LUMA (LUminometric Methylation Assay)--a high throughput method to the analysis of genomic DNA methylation. (2006) (300)
- Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. (1990) (294)
- Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. (1997) (292)
- Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families (1996) (267)
- Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. (2015) (264)
- MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. (2010) (239)
- Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus (1996) (222)
- Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors. (2003) (219)
- The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas (2014) (216)
- Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. (1992) (211)
- Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players (2019) (207)
- Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy. (1996) (204)
- Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. (1996) (192)
- Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. (1998) (189)
- Alterations of the MEN1 gene in sporadic parathyroid tumors. (1998) (184)
- The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma (2011) (183)
- Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy (2008) (178)
- BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. (1994) (174)
- Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. (1996) (161)
- Pheochromocytoma and functional paraganglioma syndrome: No longer the 10% tumor (2005) (159)
- Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids. (2001) (151)
- Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma. (2014) (148)
- Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas. (1995) (148)
- Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4/U6 snRNAs. (2009) (147)
- Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. (1993) (144)
- Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention (2017) (140)
- Characterization of the mouse Men1 gene and its expression during development (1998) (138)
- Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s. (1994) (135)
- Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria (2001) (133)
- Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. (1998) (132)
- Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma. (2015) (131)
- Genotyping of adrenocortical tumors: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. (1999) (129)
- Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping (2000) (127)
- Clinicopathologic Studies of Thymic Carcinoids in Multiple Endocrine Neoplasia Type 1 (1997) (124)
- Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. (1997) (120)
- The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. (2003) (119)
- High allele loss rates at I7q I2‐q2I in breast and ovarian tumors from BRCAI‐linked families (1995) (118)
- Loss of ZDHHC15 expression in a woman with a balanced translocation t(X;15)(q13.3;cen) and severe mental retardation (2005) (117)
- Prognostic Impact of Immunohistochemical Expression of Ezrin in Highly Malignant Soft Tissue Sarcomas (2005) (115)
- Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11. (1989) (113)
- A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. (2000) (112)
- Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology. (2000) (111)
- Patterns of chromosomal imbalances in parathyroid carcinomas. (2000) (110)
- Silencing of the PTEN tumor‐suppressor gene in anaplastic thyroid cancer (2002) (109)
- Adrenal lesion in multiple endocrine neoplasia type 1. (1995) (108)
- miR-205 Expression Promotes Cell Proliferation and Migration of Human Cervical Cancer Cells (2012) (107)
- KI-67 AND hTERT Expression Can Aid in the Distinction between Malignant and Benign Pheochromocytoma and Paraganglioma (2003) (107)
- Alternative genetic pathways in parathyroid tumorigenesis. (1999) (105)
- Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. (2007) (105)
- Menin interacts directly with the homeobox-containing protein Pem. (2001) (104)
- Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas. (2012) (103)
- A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. (1998) (101)
- Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? (1996) (97)
- Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. (1995) (96)
- Familial isolated hyperparathyroidism as a variant of multiple endocrine neoplasia type 1 in a large Danish pedigree. (2000) (96)
- A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse. (1998) (94)
- TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA (2014) (94)
- The human NOTCH1, 2, and 3 genes are located at chromosome positions 9q34, 1p13-p11, and 19p13.2-p13.1 in regions of neoplasia-associated translocation. (1994) (93)
- Identification of two distinct deleted regions on chromosome 13 in prostate cancer (1998) (92)
- Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. (1998) (89)
- Phenotype and phenocopy: the relationship between genotype and clinical phenotype in a single large family with multiple endocrine neoplasia type 1 (MEN 1) (2000) (89)
- Loss of parafibromin expression in a subset of parathyroid adenomas. (2006) (88)
- Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP) (2004) (85)
- Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10 (1993) (82)
- Genomic alterations in human breast carcinomas (1990) (82)
- Tetrasomy 15q: two marker chromosomes with no detectable alpha-satellite DNA. (1994) (82)
- Evaluation of Retinoblastoma and Ki-67 Immunostaining as Diagnostic Markers of Benign and Malignant Parathyroid Disease (1999) (81)
- Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. (1993) (81)
- Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. (1992) (80)
- The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors (2014) (76)
- Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas (2002) (76)
- Chromosomal localization of six human forkhead genes, freac-1 (FKHL5), -3 (FKHL7), -4 (FKHL8), -5 (FKHL9), -6 (FKHL10), and -8 (FKHL12). (1995) (75)
- Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPARγ fusion oncogene (2005) (73)
- Chromosomal Imbalances in Diffuse Large B-Cell Lymphoma Detected by Comparative Genomic Hybridization (2002) (72)
- Alterations of p53 and expression of WAF1/p21 in human thyroid tumors. (1996) (71)
- Transcriptional profiling enables molecular classification of adrenocortical tumours. (2009) (70)
- Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas. (1997) (69)
- Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism (1997) (69)
- Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma. (2005) (67)
- Mapping of the second locus for the Van der Woude syndrome to chromosome 1p34 (2001) (66)
- Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma. (2014) (66)
- Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia (2008) (65)
- Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping (2000) (65)
- MicroRNA Expression Patterns Related to Merkel Cell Polyomavirus Infection in Human Merkel Cell Carcinoma (2013) (65)
- Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5. (1994) (64)
- Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation. (2006) (64)
- Genetic studies of a family with hereditary hyperparathyroidism–jaw tumour syndrome (1999) (63)
- Familial periodic cerebellar ataxia without myokymia maps to a 19-cM region on 19p13. (1995) (63)
- Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma (2013) (62)
- Characterization of the human peroxisome proliferator activated receptor delta gene and its expression. (2000) (62)
- Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours (2010) (61)
- CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis. (2008) (60)
- Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7. (1992) (60)
- Parafibromin and APC as Screening Markers for Malignant Potential in Atypical Parathyroid Adenomas (2010) (59)
- Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping. (2001) (59)
- Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas. (2009) (59)
- Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears. (2009) (58)
- Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas (2006) (58)
- Loss of heterozygosity in familial breast carcinomas. (1993) (58)
- Predisposition for breast cancer in carriers of constitutional translocation 11q;22q. (1994) (57)
- MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma. (2003) (57)
- Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma. (2008) (56)
- Detailed physical map of human chromosomal region 11q12-13 shows high meiotic recombination rate around the MEN1 locus. (1991) (56)
- Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinoma (2013) (56)
- Distinct deleted regions on chromosome segment 16q23–24 associated with metastases in prostate cancer (1999) (56)
- Analysis of the cytogenetic stability of the human embryonal kidney cell line 293 by cytogenetic and STR profiling approaches (2004) (55)
- Familial non-VHL non-papillary clear-cell renal cancer (1997) (54)
- Targeted disruption of the mouse phospholipase C β3 gene results in early embryonic lethality (1998) (54)
- A PCR-based expression signature of malignancy in follicular thyroid tumors. (2007) (54)
- DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse (2004) (54)
- Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts Prognosis Independent of Histology (2018) (53)
- Molecular Markers for Discrimination of Benign and Malignant Follicular Thyroid Tumors (2006) (52)
- Gain of 1q and loss of 9q21.3‐q32 are associated with a less favorable prognosis in papillary thyroid carcinoma (2001) (52)
- Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome (2002) (52)
- Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors (2014) (52)
- Proteomic profiling of follicular and papillary thyroid tumors (2011) (51)
- Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas. (1998) (51)
- The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection (2006) (51)
- Global and Regional CpG Methylation in Pheochromocytomas and Abdominal Paragangliomas: Association to Malignant Behavior (2008) (50)
- Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of the MEN1 gene in sporadic melanoma (2000) (50)
- TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma (2014) (49)
- Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma (2012) (49)
- A novel locus (RP33) for autosomal dominant retinitis pigmentosa mapping to chromosomal region 2cen-q12.1 (2006) (49)
- Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism. (2002) (48)
- Novel functions and targets of miR-944 in human cervical cancer cells (2014) (48)
- Global and gene-specific promoter methylation analysis in primary hyperparathyroidism (2013) (47)
- Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma (2001) (47)
- Functional role of the Ca²⁺-activated Cl⁻ channel DOG1/TMEM16A in gastrointestinal stromal tumor cells. (2014) (47)
- Loss of miR-514a-3p regulation of PEG3 activates the NF-kappa B pathway in human testicular germ cell tumors (2017) (47)
- microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome (2014) (46)
- Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models. (2007) (45)
- Characterization of a novel human putative mitochondrial transporter homologous to the yeast mitochondrial RNA splicing proteins 3 and 4 (2001) (45)
- Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas (2002) (44)
- Expression of the BCL6 gene in the pre- and postnatal mouse. (1998) (44)
- Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1 (1995) (43)
- Epigenetic regulation of glucose transporter 4 by estrogen receptor β. (2011) (43)
- Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer. (2008) (42)
- A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13. (1997) (42)
- 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines (2001) (41)
- Characterization of chromosomal abnormalities in uroepithelial carcinomas by G‐banding, spectral karyotyping and FISH analysis (2001) (41)
- Human Anaplastic Thyroid Carcinoma Cells Are Sensitive to NK Cell–Mediated Lysis via ULBP2/5/6 and Chemoattract NK Cells (2014) (41)
- Expression of the RET proto‐oncogene in papillary thyroid carcinoma and its correlation with clinical outcome (2001) (40)
- Stromal Fibroblasts Adjacent to Invasive Thyroid Tumors: Expression of Gelatinase A But Not Stromelysin 3 mRNA (1996) (40)
- Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13. (2000) (40)
- Spectral karyotyping and chromosome banding studies of primary breast carcinomas and their lymph node metastases. (2000) (39)
- Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours (2011) (39)
- Two Chinese families with pulverulent congenital cataracts and deltaG91 CRYBA1 mutations. (2007) (38)
- The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion. (2006) (38)
- Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism. (2001) (38)
- GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression (2018) (38)
- Allelotyping of follicular thyroid tumors (1995) (38)
- Evidence of a functional estrogen receptor in parathyroid adenomas. (2012) (37)
- Familial non-syndromic cleft lip and palate--analysis of the IRF6 gene and clinical phenotypes. (2008) (37)
- Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization (2013) (36)
- Characteristic sequence motifs located at the genomic breakpoints of the translocation t(X;18) in synovial sarcomas (2003) (36)
- The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors. (1996) (36)
- Expression and association of TRPC subtypes with Orai1 and STIM1 in human parathyroid. (2010) (35)
- Genetic characterization of large parathyroid adenomas (2012) (35)
- Recurrent genomic alterations in benign and malignant pheochromocytomas and paragangliomas revealed by whole-genome array comparative genomic hybridization analysis. (2010) (35)
- Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma. (2007) (35)
- Structure and localization of the human insulin-like growth factor-binding protein 2 gene. (1991) (34)
- Homozygotes for the autosomal dominant neoplasia syndrome (MEN1). (1993) (34)
- Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma. (2000) (34)
- Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival. (2004) (34)
- Telomerase-Dependent and Independent Telomere Maintenance and its Clinical Implications in Medullary Thyroid Carcinoma (2014) (34)
- TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours. (2018) (33)
- Novel and recurrent KIF21A mutations in congenital fibrosis of the extraocular muscles type 1 and 3. (2008) (33)
- Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma (2016) (32)
- Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism. (2002) (32)
- The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma. (2007) (32)
- Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma. (2010) (32)
- Loss of Heterozygosity on the Short Arm of Chromosome 1 in Pheochromocytoma and Abdominal Paraganglioma (2002) (31)
- Molecular cloning, characterization, and chromosomal localization of a human lymphoid tyrosine kinase related to murine Blk. (1995) (31)
- Localization of the human soluble epoxide hydrolase gene (EPHX2) to chromosomal region 8p21-p12 (1995) (31)
- Expression of the VEGF-related factor gene in pre- and postnatal mouse. (1996) (31)
- miR-223-3p regulates cell growth and apoptosis via FBXW7 suggesting an oncogenic role in human testicular germ cell tumors (2016) (31)
- Low frequency of numerical chromosomal aberrations in follicular thyroid tumors detected by comparative genomic hybridization (1999) (31)
- Anaplastic carcinoma of the thyroid gland: Treatment and outcome over 13 years at one institution (2012) (31)
- Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma (2007) (31)
- Amplification of 2p as a Genomic Marker for Transformation in Lymphoma (2014) (30)
- Fine mapping of Best's macular dystrophy localizes the gene in close proximity to but distinct from the D11S480/ROM1 loci. (1994) (30)
- Identifying cancer-related genes in nasopharyngeal carcinoma cell lines using DNA and mRNA expression profiling analyses. (2002) (30)
- No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours (1999) (29)
- Balanced translocation (3;7)(p25;q34): another mechanism of tumorigenesis in follicular thyroid carcinoma? (2000) (28)
- Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy. (2009) (28)
- Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas. (2002) (27)
- HRAS mutation prevalence and associated expression patterns in pheochromocytoma (2016) (27)
- Distinction in gene expression profiles demonstrated in parathyroid adenomas by high-density oligoarray technology. (2005) (27)
- Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array‐CGH (2006) (27)
- Sporadic follicular thyroid tumors show loss of a 200‐kb region in 11q13 without evidence for mutations in the MEN1 gene (1999) (27)
- Novel and de novo mutations of the IRF6 gene detected in patients with Van der Woude or popliteal pterygium syndrome (2005) (27)
- Chromosomal aberrations in benign and malignant Bilharzia-associated bladder lesions analyzed by comparative genomic hybridization (2002) (27)
- Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas. (2005) (26)
- Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis. (2009) (26)
- Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma. (2001) (26)
- Characterisation of the human APC1, the largest subunit of the anaphase-promoting complex. (2001) (26)
- Sporadic primary hyperparathyroidism in the setting of multiple endocrine neoplasia type 1. (1996) (26)
- Mantle cell lymphomas with clonal immunoglobulin VH3–21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin VH genes (2005) (25)
- Multiple endocrine neoplasia type 1. (2000) (25)
- Gelatinase A and Membrane-type 1 Matrix Metalloproteinase mRNA: Expressed in Adrenocortical Cancers but Not in Adenomas (1999) (25)
- Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas. (2008) (25)
- CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome. (2001) (25)
- miR‐125a‐5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors (2018) (25)
- Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease (2019) (25)
- Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas (2000) (25)
- Structure and chromosomal localization of human insulin-like growth factor-binding protein genes. (1993) (24)
- Genetic Screening for MEN1 Mutations in Families Presenting with Familial Primary Hyperparathyroidism (2002) (24)
- Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas. (2000) (24)
- Genome-Wide and Locus Specific Alterations in CDC73/HRPT2-Mutated Parathyroid Tumors (2012) (23)
- Minimally invasive follicular thyroid carcinomas: prognostic factors (2016) (23)
- High level amplification of 1p32-33 and 2p22-24 in small cell lung carcinomas. (2001) (23)
- Multiple endocrine neoplasia type I and Cushing's syndrome due to an aggressive ACTH producing thymic carcinoid. (2006) (23)
- Multiple endocrine neoplasia. (1990) (23)
- Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene. (2003) (23)
- Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation (2012) (23)
- Molecular characterization of a recurring complex chromosomal translocation in two human extragonadal germ cell tumors. (1994) (23)
- Mutation analysis of the BRG1 gene in prostate cancer clinical samples. (2003) (23)
- Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors (2021) (22)
- Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors (1996) (22)
- MiR-375 Regulation of LDHB Plays Distinct Roles in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma (2018) (22)
- Clinical and genetic studies of Van der Woude syndrome in Sweden. (1999) (22)
- Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas (2012) (22)
- Differential Protein Expression Profiles of Cyst Fluid from Papillary Thyroid Carcinoma and Benign Thyroid Lesions (2015) (22)
- Bilateral multiple renal oncocytomas and cysts associated with a constitutional translocation (8;9)(q24.1;q34.3) and a rare constitutional VHL missense substitution (1998) (21)
- Molecular Profiling of Pheochromocytoma and Abdominal Paraganglioma Stratified by the PASS Algorithm Reveals Chromogranin B as Associated With Histologic Prediction of Malignant Behavior (2019) (21)
- Localization and identification of the multiple endocrine neoplasia type 1 disease gene. (1994) (21)
- Cloning and characterization of ZNF189, a novel human Krüppel-like zinc finger gene localized to chromosome 9q22-q31. (1998) (21)
- Expression and chromosomal localization of the Requiem gene (1998) (21)
- Exclusion of FAU as the multiple endocrine neoplasia type 1 (MEN1) gene. (1993) (21)
- Gain of 17q in malignant fibrous histiocytoma is associated with a longer disease-free survival and a low risk of developing distant metastasis (2003) (21)
- Cytogenetic and expression profiles associated with transformation to androgen‐resistant prostate cancer (2006) (21)
- Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition (2009) (21)
- Genetic analysis of lithium-associated parathyroid tumors. (2002) (21)
- Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland (2001) (21)
- Characterization of large chromosome markers in a malignant fibrous histiocytoma by spectral karyotyping, comparative genomic hybridization (CGH), and array CGH. (2004) (21)
- Cell type and context-specific function of PLAG1 for IGF2 P3 promoter activity (2012) (20)
- Predictors of outcome in patients with papillary thyroid carcinoma. (2006) (20)
- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (1997) (20)
- Molecular Characterization of Acquired Tolerance of Tumor Cells to Picropodophyllin (PPP) (2011) (20)
- MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas. (2014) (20)
- Genetic and clinical characterization of sporadic cystic parathyroid tumours (2002) (20)
- MicroRNA expression profiles in non-epithelial ovarian tumors (2017) (20)
- A dog pedigree with familial medullary thyroid cancer. (2006) (20)
- Merkel cell polyomavirus oncoproteins induce microRNAs that suppress multiple autophagy genes (2019) (20)
- Identification of numerical and structural chromosome aberrations in 15 high hyperdiploid childhood acute lymphoblastic leukemias using spectral karyotyping (2001) (20)
- GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours (2020) (19)
- Linkage analysis with markers on 17q in 29 Swedish breast cancer families. (1993) (18)
- Genetic mapping of the multiple endocrine neoplasia type 1 locus at 11q13 (1995) (18)
- Inhibition of Parathyroid Hormone Secretion by Caffeine in Human Parathyroid Cells (2013) (18)
- Genomic organization and complete cDNA sequence of the human phosphoinositide-specific phospholipase C beta 3 gene (PLCB3). (1995) (18)
- Linkage analysis of candidate regions in Swedish nonsyndromic cleft lip with or without cleft palate families. (2000) (18)
- Assignment of the human FAU gene to a subregion of chromosome 11q13. (1993) (18)
- Human histone deacetylase 2, HDAC2 (Human RPD3), is localized to 6q21 by radiation hybrid mapping. (1998) (18)
- Chromosomal distribution, localization and expression of the human endogenous retrovirus ERV9 (2001) (17)
- Linkage disequilibrium studies in multiple endocrine neoplasia type 1 (MEN1) (1997) (17)
- Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma (2008) (17)
- Tumor suppressor genes (TSG). (1999) (17)
- Complete characterization of a large marker chromosome by reverse and forward chromosome painting (1992) (17)
- Lack of S37A CTNNB1/β‐catenin mutations in a Swedish cohort of 98 parathyroid adenomas (2010) (17)
- Epigenetic Aspects on Therapy Development for Gastroenteropancreatic Neuroendocrine Tumors (2012) (17)
- Allelic loss on chromosome 11 is uncommon in parathyroid glands of patients with hypercalcaemic secondary hyperparathyroidism. (1997) (17)
- TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up (2019) (16)
- Multiple endocrine neoplasia type I: clinical syndrome to molecular genetics. (1995) (16)
- Suppression of RIZ in biologically unfavourable neuroblastomas. (2010) (16)
- The VHL gene is epigenetically inactivated in pheochromocytomas and abdominal paragangliomas (2013) (16)
- Wide Surgical Margin Improves the Outcome for Patients with Gastrointestinal Stromal Tumors (GISTs) (2018) (16)
- The pattern of gene expression and gene dose profiles of 6-Mercaptopurine- and 6-Thioguanine-resistant human leukemia cells. (2011) (15)
- Intracellular concentration of the tyrosine kinase inhibitor imatinib in gastrointestinal stromal tumor cells (2014) (15)
- Fine mapping of the locus for nevoid basal cell carcinoma syndrome on chromosome 9q. (1997) (15)
- Multiple endocrine neoplasia type 1 (MEN1): genetic and clinical analysis in the Southern Chinese (2003) (15)
- Heterogeneous expression of SNARE proteins SNAP-23, SNAP-25, Syntaxin1 and VAMP in human parathyroid tissue (2008) (15)
- Chromosome localization, sequence analysis, and expression pattern identify FKHL 18 as a novel human forkhead gene. (1997) (15)
- Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors. (2005) (15)
- High Extracellular Ca2+ Hyperpolarizes Human Parathyroid Cells via Ca2+-activated K+ Channels* (2003) (15)
- Genetic studies of thymic carcinoids in multiple endocrine neoplasia type 1. (1994) (15)
- Genetic and clinical characteristics of multiple endocrine neoplasia type 1. (1991) (14)
- Oculopharyngeal muscular dystrophy (OPMD)‐report and genetic studies of an Australian kindred (1997) (14)
- Pre-fractionation of archival frozen tumours for proteomics applications. (2006) (14)
- Aberrations of centrosomes in adrenocortical tumors. (2002) (14)
- Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas. (2000) (14)
- New chromosomal breakpoints in non-Hodgkin's lymphomas revealed by spectral karyotyping and G-banding. (2000) (14)
- Evaluation of spectral karyotyping (SKY) in biodosimetry for the triage situation following gamma irradiation (2006) (13)
- Enhanced effects by 4-phenylbutyrate in combination with RTK inhibitors on proliferation in brain tumor cell models. (2011) (13)
- High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma (2018) (13)
- Evaluation of immunohistochemical parameters as prognostic markers in malignant fibrous histiocytoma. (2003) (13)
- Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma. (2011) (13)
- Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumors. (2013) (13)
- Molecular cytogenetic characterization of four commonly used cell lines derived from Hodgkin lymphoma. (2003) (13)
- Isolation and characterization of a novel gene close to the human phosphoinositide-specific phospholipase C beta 3 gene on chromosomal region 11q13. (1996) (13)
- EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance (2019) (13)
- TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma. (2018) (13)
- TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker. (2017) (13)
- Cloning and characterization of freac-9 (FKHL17), a novel kidney-expressed human forkhead gene that maps to chromosome 1p32-p34. (1997) (12)
- Characterization and chromosomal localization of the human insulin-like growth factor-binding protein 6 gene (1999) (12)
- Molecular genetics of primary and secondary hyperparathyroidism. (2009) (12)
- Telomerase reverse transcriptase promoter hypermethylation is associated with metastatic disease in abdominal paraganglioma (2018) (12)
- Characterization of a putative murine mitochondrial transporter homology of hMRS3/4 (2001) (12)
- Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition. (2009) (12)
- Malignant Fibrous Histiocytoma, Aggressive Fibromatosis and Benign Fibrous Tumors Express mRNA for the Metalloproteinase Inducer EMMPRIN and the Metalloproteinases MMP-2 and MT1-MMP (2001) (12)
- Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight (2015) (12)
- Hyperparathyroidism of multiple endocrine neoplasia type 1: candidate gene and parathyroid calcium sensing protein expression. (1995) (11)
- Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas (1993) (11)
- Biochemical Inhibition of DOG1/TMEM16A Achieves Antitumoral Effects in Human Gastrointestinal Stromal Tumor Cells In Vitro (2019) (11)
- Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor (2020) (11)
- Exclusion of the phosphoinositide-specific phospholipase Cβ3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1 (1996) (11)
- Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus (1992) (11)
- Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors (2016) (10)
- A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis (2017) (10)
- PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma (2020) (10)
- Candidate genes for multiple endocrine neoplasia type 1 (1995) (10)
- Morphology, DNA ploidy and allele losses on chromosome 11 in sporadic hyperparathyroidism and that associated with multiple neoplasia, type 1. (1992) (10)
- A rapid method for DNA extraction from fine-needle aspiration biopsies of thyroid tumors, and subsequent RET mutation analysis. (1998) (10)
- Homozygous inactivation of the MEN1 gene as a specific somatic event in a case of secondary hyperparathyroidism. (2001) (9)
- TERT promoter mutations are rare in parathyroid tumors. (2015) (9)
- Expression analysis of RET and the GDNF/GFRalpha-1 and NTN/GFRalpha-2 ligand complexes in pheochromocytomas and paragangliomas. (2000) (9)
- Expression of the phosphoinositide‐specific phospholipase Cβ3 gene in the rat (1995) (9)
- Genetic background of adrenocortical tumor development (2001) (9)
- Genetic aspects of multiple endocrine neoplasia types 1 and 2. (1994) (9)
- Molecular Genetics of Familial Hyperparathyroidism (2001) (9)
- Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1). (1996) (9)
- Genetics of Multiple Endocrine Neoplasia Type 1 a (1994) (9)
- Charcot-Marie-Tooth disease and Noonan syndrome with giant proximal nerve hypertrophy (1998) (8)
- Hereditary breast cancer in sweden: a predominance of maternally inherited cases (2005) (8)
- Expression of matrix metalloproteinase gelatinase A messenger ribonucleic acid in parathyroid carcinomas. (1999) (8)
- Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors (2021) (8)
- Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers. (2004) (8)
- Family Screening in Multiple Endocrine Type 1 (MEN 1) Neoplasia (1994) (8)
- Spatial distribution patterns of clinically relevant TERT promoter mutations in follicular thyroid tumors of uncertain malignant potential (FT-UMPs): advantages of the digital droplet PCR (ddPCR) technique. (2020) (8)
- Suppression of the neoplastic phenotype by transfection of phospholipase C β 3 to neuroendocrine tumor cells (1999) (8)
- Overexpression of cytochrome P450 2A6 in adrenocortical carcinoma (2017) (8)
- Novel splicing of an IGF2 polymorphic region in human adrenocortical carcinomas. (1997) (8)
- Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes (2012) (8)
- Rearrangement of proximal 11q13 band in a CMML in acute transformation. (1995) (8)
- Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center (2022) (7)
- Molecular profiles of oxyphilic and chief cell parathyroid adenoma (2017) (7)
- Genetic heterogeneity and exclusion of a modifying locus at 17p11.2-p11.1 in Finnish families with van der Woude syndrome (2001) (7)
- Role of SDHAF2 and SDHD in von Hippel–Lindau Associated Pheochromocytomas (2014) (7)
- Restriction map of a YAC and cosmid contig encompassing the oculopharyngeal muscular dystrophy candidate region on chromosome 14q11.2-q13. (1998) (7)
- Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas (2016) (7)
- Prolactin Receptor in Primary Hyperparathyroidism – Expression, Functionality and Clinical Correlations (2012) (7)
- Immunophenotypic and molecular cytogenetic features of the cell line UP-LN1 established from a lymph node metastasis of a poorly-differentiated carcinoma. (2005) (7)
- Two Chinese families with pulverulent congenital cataracts and ∆ G 91 CRYBA 1 mutations (2007) (7)
- Differential expression of multiple alternative spliceforms of the Men1 tumor suppressor gene in mouse. (2001) (7)
- Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors (2019) (6)
- Expression of the p53 Target Wig-1 Is Associated with HPV Status and Patient Survival in Cervical Carcinoma (2014) (6)
- Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate gene for multiple endocrine neoplasia type 1 (1995) (6)
- Secretome protein signature of human gastrointestinal stromal tumor cells. (2015) (6)
- Proteomic Profiling of Diffuse Large B-Cell Lymphomas (2018) (6)
- Diffuse PTH expression in parathyroid tumors argues against important functional tumor subclones (2016) (6)
- Imatinib Regulates miR-483-3p and Mitochondrial Respiratory Complexes in Gastrointestinal Stromal Tumors (2021) (5)
- Mapping of the gene encoding the B56β subunit of protein phosphatase 2A (PPP2R5B) to a 0.5-Mb region of chromosome 11q13 and its exclusion as a candidate gene for multiple endocrine neoplasia type 1 (MEN1) (1997) (5)
- Linkage Analysis of Candidate Regions in Swedish Nonsyndromic Cleft Lip with or without Cleft Palate Families (2000) (5)
- Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesions (2017) (5)
- Fine mapping of the MLK-3 gene within 11q13 and its exclusion as the MEN1 susceptibility gene (1997) (5)
- Loss of chromosome 13q is a frequently acquired event in genetic progression of soft tissue sarcomas in the abdominal cavity. (2005) (5)
- Familial testicular cancer: lack of evidence for trinucleotide repeat expansions and association with PKD1 in one family (1999) (5)
- LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer (2018) (5)
- Direct interaction of the ATP-sensitive K+ channel by the tyrosine kinase inhibitors imatinib, sunitinib and nilotinib. (2021) (4)
- A putative human zinc-finger gene (ZFPL1) on 11q13, highly conserved in the mouse and expressed in exocrine pancreas. The European Consortium on MEN 1. (1998) (4)
- Multiple endocrine neoplasia type 1 and the search for the genetic trigger. (1997) (4)
- Parathyroid tumorigenesis in association with primary hyperparathyroidism (2002) (4)
- Presentation, Management, and Outcomes of Urinary Bladder Paraganglioma: Results from a Multi-center Study. (2022) (4)
- Functional characterization of novel germline TP53 variants in Swedish families (2019) (4)
- Family screening in multiple endocrine neoplasia type 1 (MEN 1). (1994) (4)
- Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features (2022) (4)
- Detailed characterization of a complex karyotype in a patient with primary plasma cell leukaemia using multicolour spectral karyotyping and micro-FISH. (2000) (4)
- Signaling Pathway Regulated by Intramembrane Proteolysis Fusion Mutation Identifies a Thyroid γ CREB 3 L 2-PPAR Updated (2008) (4)
- Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma. (2022) (4)
- Molecular genetics of adrenal cortical tumors (1999) (4)
- Practical guidelines for DNA-based testing in multiple endocrine neoplasia type 1. (1992) (4)
- Spontaneously immortalized human T lymphocytes develop gain of chromosomal region 2p13–24 as an early and common genetic event (2004) (4)
- Activation of RAS Signalling is Associated with Altered Cell Adhesion in Phaeochromocytoma (2020) (3)
- Localization of the human insulin-like growth-factor-binding protein 4 gene to chromosomal region 17q12–21.1 (1992) (3)
- 16th European Colloqium on Animal Cytogenetics and Gene Mapping (2004) (3)
- Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool? (2021) (3)
- Sublocalization of the multiple endocrine neoplasia type 1 gene. (1992) (3)
- Association between Predicted Effects of TP53 Missense Variants on Protein Conformation and Their Phenotypic Presentation as Li-Fraumeni Syndrome or Hereditary Breast Cancer (2021) (3)
- The mouse homologs of RELA and MLK3 are located within a 120-kb fragment on Chromosome 19 (1997) (2)
- Inflammatory infiltrates in parathyroid tumors (2017) (2)
- Assignment of the mouse homologue of a human MEN1 candidate gene, phospholipase C-beta 3 (Plcb3), to chromosome region 19B by FISH. (1995) (2)
- Copy number alterations in small intestinal neuroendocrine tumors determined by array comparative genomic hybridization (2013) (2)
- Telomerase activation in small intestinal neuroendocrine tumours is associated with aberrant TERT promoter methylation, but not hot-spot mutations (2019) (2)
- Alternative splicing in neuroblastoma generates RNA-fusion transcripts and is associated with vulnerability to spliceosome inhibitors (2019) (2)
- Clonal development of a blastoid mantle cell lymphoma studied with comparative genomic hybridization. (2002) (2)
- Loss of Heterozygosity in Familial Breast Carcinomas 1 (2006) (2)
- Malignant fibrous histiocytoma , aggressive fibromatosis and benign fibrous tumors express mRNA for the metalloproteinase inducer EMMPRIN and the metalloproteinases MMP-2 and MT 1-MMP (2014) (2)
- A highly aggressive primitive mesenchymal tumor with a translocation (1;19)(q12;q13.2). (2001) (2)
- Multiple endocrine neoplasia type 1 (MEN1) in two Asian families (1994) (2)
- A 10-year-old girl with bifocal synovial sarcoma. (2006) (2)
- Merkel cell polyomavirus T-antigens regulate DICER1 mRNA stability and translation through HSC70 (2021) (2)
- Lack of mutations in the TSHr and Gsalpha genes in TSHr antibody negative Graves' disease. (2005) (2)
- Molecular characterization of human and murine C11orf5, a new member of the FAUNA gene cluster (2000) (1)
- Loss of constitutional heterozygosity in human cancer: A practical approach (1995) (1)
- Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel–Lindau syndrome (2022) (1)
- Ordered Phosphorylation Governs Oscillation of a Three-Protein Circadian Clock (2007) (1)
- An EcoRI RFLP at the human insulin-like growth factor binding protein 2 gene (IGFBP2). (1992) (1)
- Abstract 1849: High nuclear expression of the p53 target Wig-1 is associated with poor prognosis in cervical carcinoma (2014) (1)
- Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer (2022) (1)
- Homozygosity at the dopamine D 3 receptor locus is not associated with schizophrenia (2004) (1)
- A human homologue of the rat rab geranylgeranyl transferase beta subunit on chromosome 1p22-p31. (1996) (1)
- Erratum: The human mammary-derived growth inhibitor (MDGI) gene: Genomic structure and mutation analysis in human breast tumors (Genomics (1996) 34:1 (63-68)) (1996) (1)
- Splicing-sensitive fusion transcripts associated with key tumor characteristics occur at high frequency in neuroblastoma (2019) (1)
- Follicular thyroid tumors: clinical and genetic aspects (2002) (1)
- Instructions for the preparation of gene mapping reports (1995) (1)
- 134 Functional role of merkel cell polyomavirus T-antigen regulated microRNAs in merkel cell carcinoma (2018) (0)
- MUTATIONSOFCODON 918 INTHE RET PROTO-ONCOGENECORRELATE TOPOORPROGNOSISINSPORADIcMEDULLARYTHYROIDCARCINOMAS (1995) (0)
- RNA Interference Targeting Thiopurine Methyl Transferase Gene Alters the Cytotoxic Effect of the 6-Mercaptopurine In Human Leukaemia Cells (2010) (0)
- Author response for "Functional characterization of novel pathogenic germline TP53 variants in Swedish families" (2018) (0)
- Abstract 4940: Microrna expression profiling in adrenocortical neoplasia: Implications on tumor size and functionality (2011) (0)
- INSIGHTS INTO THE TRANSCRIPTOMIC PROFILING OF ADRENOCORTICAL TUMORS (2013) (0)
- Subject Index Vol. 47, 1997 (1997) (0)
- Abstract 1141: Telomerase activity in relation toRETmutation status in medullary thyroid carcinoma (2012) (0)
- RF33 | PSUN02 Presentation, Management, and Outcomes of Urinary Bladder Paraganglioma: Results from a Multi-center Study (2022) (0)
- Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre‐operative identification of high‐risk cases (2023) (0)
- Abstract LB-219: Elevated expression of cellular proliferative index MIB-1 in post-Chornobyl papillary thyroid carcinoma with coexisting thyroiditis (2010) (0)
- Comprehensive analysis of genetic alterations associated with androgen-resistant prostate cancer transformation using SKY, CGH and cDNA microarray (2004) (0)
- New growth factor and gene sequence encoding it. (1996) (0)
- Expression of the RET proto‐oncogene and the RET/PTC oncogenes in papillary thyroid carcinomas and its correlation to clinical manifestations (2000) (0)
- Contents, Vol. 47, 1997 (1997) (0)
- Molecular analysis of chromosomal translocations in human extragonadal germ cell tumors (1994) (0)
- Methods for detecting the progression of cervical dysplasia mild AD (2006) (0)
- TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome? (2023) (0)
- Prevention Medicine in Bilateral Phaeochromocytoma (2018) (0)
- A novel growth factor and a genetic sequence coding for these (1996) (0)
- Acute myeloid leukemia - Apoptotic signalling and gene expression associated with treatment response (2013) (0)
- 739 Altered expression of miR-205 affects cell proliferation in human cervical cancer (2010) (0)
- Characterization of gene specific methylation in pheochromocyotmas/abdominal paragangliomas: Correlation with malignant behavior (2007) (0)
- Hereditary primary hyperparathyroidism and multiple endocrine neoplasia (2014) (0)
- Characterization of complex chromosomal translocations in two pseudodiploid extragonadal germ cell tumors using fluorescence in situ hybridization (1992) (0)
- 38th Biennial American Cytogenetics Conference (2004) (0)
- Global and Regional CpGMethylation in Pheochromocytomas and Abdominal Paragangliomas : Association toMalignant Behavior (2008) (0)
- P69: Identification of genes in neuroendocrine tumor development using microarray-CGH (2005) (0)
- Mutation Analysis of KIF21A Gene in 5 Chinese Families With Congenital Fibrosis of the Extraocular Muscles Type 1 and 3 (2008) (0)
- 889 The involvement of miR-483 and its host gene IGF2 in development of adrenal cortical carcinoma (2010) (0)
- 503Deletion of chromosomal region 14Q31-Q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival (2005) (0)
- Altered expression of the IGF2-H19 locus and mitochondrial respiratory complexes in adrenocortical carcinoma (2022) (0)
- Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer (2023) (0)
- [The first breast cancer gene isolated. Safer risk assessment for affected families]. (1995) (0)
- Methods for detecting the development of cervical dysplasia low grade. (2006) (0)
- Molecular cytogenetic characterization of anaplastic thyroid carcinoma (2006) (0)
- Abstract 5317: Evidence for intracellular calcium-regulated secretion in gastrointestinal stromal tumor. (2013) (0)
- REGULATION OF CELLULAR DEGRADATION PATHWAYS BY VIRAL ONCOPROTEINS AND MICRORNAS (2020) (0)
- Gene identification in autosomal dominant disorders. (1997) (0)
- Immediate action of imatinib mesylate on calcium signaling in gastrointestinal stromal tumors (GIST). (2011) (0)
- DLEU2, Located within the CLL 13q14 Deletion Locus, Encodes an Antisense RNA for the Putative Bicistronic RFP2/LEU5 Gene in Humans and Mouse. (2004) (0)
- Mapping of the human Ca2+ channel β4 subunit to 2q22-23 and its expression in developing mouse (1998) (0)
- Cytogenetic characterization, frequency and distribution of rob t(1;29) in some Italian and Portuguese cattle breeds (2004) (0)
- Abstract 3462: Proteomic profiling reveals novel targets for combination treatment with lanreotide in neuroendocrine tumors (2015) (0)
- ThymicCarcinoids inMultiple Endocrine Neoplasia Type1 (1998) (0)
- Mapping of the gene for multiple endocrine neoplasia type I to chromosome 11q13. (1989) (0)
- Identification of twelve new RFLP-markers on chromosome 22q11-qter (1991) (0)
- 732 Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphomas (2010) (0)
- On 13 q 14 deletions in chronic lymphocytic leukemia (2008) (0)
- The new growth factor and its encoding gene sequence (1997) (0)
- A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis (2017) (0)
- Molecular characterization of parathyroid tumors from two patients with hereditary colorectal cancer syndromes (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Catharina Larsson?
Catharina Larsson is affiliated with the following schools:
